The Filing Desk

Axil Brands vs Bioharvest Sciences

Axil Brands AXIL · Bioharvest Sciences BHST · Personal Care Products

Bioharvest Sciences reported revenue of $34 million in fiscal 2025, about the same as Axil Brands' $31 million in fiscal 2026. Axil Brands' revenue grew 17.5% in its latest year, and Bioharvest Sciences' grew 37.0%. Axil Brands had an operating margin of 9.7%, against -16.2% at Bioharvest Sciences. Free cash flow was −$0 million at Axil Brands and −$10 million at Bioharvest Sciences. Their fiscal years end in different months (May 31 and December 31), so the periods don't line up exactly.

Side by side

Axil BrandsBioharvest Sciences
Latest fiscal yearFY2026, May 31, 2026FY2025, Dec 31, 2025
Revenue$31M$34M
Revenue growth17.5%37.0%
Revenue growth a year, last 5 years80.7%—
Gross margin69.3%59.3%
Operating margin9.7%−16.2%
Net margin8.8%−32.3%
Free cash flow−$0M−$10M
Free cash flow margin−0.3%−27.8%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count0.5%—
Last close$4.50$1.32
P/E at the last close13.2×—
Insider trades, last 12 months——
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Axil BrandsBioharvest Sciences
Operating margin
Percent of revenue
Axil BrandsBioharvest Sciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Axil BrandsBioharvest Sciences

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Axil Brands and Bioharvest Sciences pages.